
|Videos|February 18, 2021
New Deterrent Stimulants for ADHD
Author(s)Timothy Wilens, MD
What observations are being noted in the field with new agents for the treatment of ADHD?
Advertisement
Timothy Wilens, MD, talks about the presentation of the APSARD 2021 conference on ADAIR Pharmacokinetics and Pharmacodynamic Data. More on the presentation can be found
Dr Wilens is chief of the Division of Child and Adolescent Psychiatry and is co-director of the Center for Addiction Medicine at Massachusetts General Hospital.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Postpartum Psychosis on Trial: What the Lindsay Clancy Case Can Teach Us
2
Bringing Wearable Data Into Psychiatric Care: Amae Health Partners With Google Health Enterprise to Improve Outcomes
3
Centanafadine in ADHD: Clinical Significance of the First Triple Reuptake Inhibitor for ADHD
4
How Wearable Tech Can Translate Into Practical Precision Medicine in Psychiatry
5











